Clinical trial
GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of…
NCT00336336 · Gruppo di Ricerca GISSI, Other · Completed
Key facts
| NCT number | NCT00336336 |
|---|---|
| Title | GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic CHF |
| Official title | A Large Scale Clinical Trial Testing the Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic Congestive Heart Failure |
| Lead sponsor | Gruppo di Ricerca GISSI, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Heart Failure |
| Intervention type | Drug |
| Interventions | n-3 PUFA, Rosuvastatin, Placebo |
| Enrollment | 6,975 |
| Start date | Aug 1, 2002 |
| Primary completion | Apr 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jun 13, 2006 |
| Last update posted | Aug 14, 2015 |
| Countries | Italy, Switzerland |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: